Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish
Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low d...
Saved in:
Published in | Toxicological sciences Vol. 146; no. 2; pp. 235 - 243 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
01.08.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low doses of the pyrethroid deltamethrin results in persistent alterations in dopaminergic gene expression, neurochemistry, and locomotor activity. Zebrafish embryos were treated with deltamethrin (0.25-0.50 μg/l), at concentrations below the LOAEL, during the embryonic period [3-72 h postfertilization (hpf)], after which transferred to fresh water until the larval stage (2-weeks postfertilization). Deltamethrin exposure resulted in decreased transcript levels of the D1 dopamine (DA) receptor (drd1) and increased levels of tyrosine hydroxylase at 72 hpf. The reduction in drd1 transcripts persisted to the larval stage and was associated with decreased D2 dopamine receptor transcripts. Larval fish, exposed developmentally to deltamethrin, had increased levels of homovanillic acid, a DA metabolite. Since the DA system is involved in locomotor activity, we measured the swim activity of larval fish following a transition to darkness. Developmental exposure to deltamethrin significantly increased larval swim activity which was attenuated by concomitant knockdown of the DA transporter. Acute exposure to methylphenidate, a DA transporter inhibitor, increased swim activity in control larva, while reducing swim activity in larva developmentally exposed to deltamethrin. Developmental exposure to deltamethrin causes locomotor deficits in larval zebrafish, which is likely mediated by dopaminergic dysfunction. This highlights the need to understand the persistent effects of low-dose neurotoxicant exposure during development. |
---|---|
AbstractList | Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low doses of the pyrethroid deltamethrin results in persistent alterations in dopaminergic gene expression, neurochemistry, and locomotor activity. Zebrafish embryos were treated with deltamethrin (0.25–0.50 μg/l), at concentrations below the LOAEL, during the embryonic period [3–72 h postfertilization (hpf)], after which transferred to fresh water until the larval stage (2-weeks postfertilization). Deltamethrin exposure resulted in decreased transcript levels of the D1 dopamine (DA) receptor (
drd1
) and increased levels of tyrosine hydroxylase at 72 hpf. The reduction in
drd1
transcripts persisted to the larval stage and was associated with decreased D2 dopamine receptor transcripts. Larval fish, exposed developmentally to deltamethrin, had increased levels of homovanillic acid, a DA metabolite. Since the DA system is involved in locomotor activity, we measured the swim activity of larval fish following a transition to darkness. Developmental exposure to deltamethrin significantly increased larval swim activity which was attenuated by concomitant knockdown of the DA transporter. Acute exposure to methylphenidate, a DA transporter inhibitor, increased swim activity in control larva, while reducing swim activity in larva developmentally exposed to deltamethrin. Developmental exposure to deltamethrin causes locomotor deficits in larval zebrafish, which is likely mediated by dopaminergic dysfunction. This highlights the need to understand the persistent effects of low-dose neurotoxicant exposure during development. Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are more susceptible to the adverse effects of pesticides. We used the zebrafish model to test the hypothesis that developmental exposure to low doses of the pyrethroid deltamethrin results in persistent alterations in dopaminergic gene expression, neurochemistry, and locomotor activity. Zebrafish embryos were treated with deltamethrin (0.25-0.50 μg/l), at concentrations below the LOAEL, during the embryonic period [3-72 h postfertilization (hpf)], after which transferred to fresh water until the larval stage (2-weeks postfertilization). Deltamethrin exposure resulted in decreased transcript levels of the D1 dopamine (DA) receptor (drd1) and increased levels of tyrosine hydroxylase at 72 hpf. The reduction in drd1 transcripts persisted to the larval stage and was associated with decreased D2 dopamine receptor transcripts. Larval fish, exposed developmentally to deltamethrin, had increased levels of homovanillic acid, a DA metabolite. Since the DA system is involved in locomotor activity, we measured the swim activity of larval fish following a transition to darkness. Developmental exposure to deltamethrin significantly increased larval swim activity which was attenuated by concomitant knockdown of the DA transporter. Acute exposure to methylphenidate, a DA transporter inhibitor, increased swim activity in control larva, while reducing swim activity in larva developmentally exposed to deltamethrin. Developmental exposure to deltamethrin causes locomotor deficits in larval zebrafish, which is likely mediated by dopaminergic dysfunction. This highlights the need to understand the persistent effects of low-dose neurotoxicant exposure during development. |
Author | White, Lori A Richardson, Jason R Cooper, Keith R Kung, Tiffany S |
Author_xml | – sequence: 1 givenname: Tiffany S surname: Kung fullname: Kung, Tiffany S organization: Joint Graduate Program in Toxicology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA, Department of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA and – sequence: 2 givenname: Jason R surname: Richardson fullname: Richardson, Jason R organization: Department of Environmental and Occupational Medicine, Environmental and Occupational Health Sciences Institute, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA – sequence: 3 givenname: Keith R surname: Cooper fullname: Cooper, Keith R organization: Department of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA and Department of Environmental and Occupational Medicine, Environmental and Occupational Health Sciences Institute, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA – sequence: 4 givenname: Lori A surname: White fullname: White, Lori A email: lawhite@aesop.rutgers.edu organization: Department of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA and lawhite@aesop.rutgers.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25912032$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkctOwzAQRS0EouWxZIv8AYT6kTjJBgm1vKQKWMCGTeQ4k8aQ2JHtVvQ3-GJSFSpYzWjm3jMa3SO0b6wBhM4ouaQk55NgP73Sk496RbJ0D42HoYhIzvL9n16QjIzQkffvhFAqSH6IRizJKSOcjdHXDFbQ2r4DE2SLZ9AG2UFonDb45rO3fukAT-XSg8fP4Lz2YVDiaSPNYhgNqpntZacNuIVW-A4MbHwOvNfWXOBHWDqrGugGo1tfYGkqPLfKdjZYh69V0Csd1hvOG5RO1to3J-iglq2H0596jF5vb16m99H86e5hej2PFM_SENFY1gAZkUTmleJC1TEkschKyuuYVawkFRNxXCZQSiEZCAEZy1jKKiA1j1N-jK623H5ZdlCp4S8n26J3upNuXVipi_8bo5tiYVdFnNCUJHwARFuActZ7B_XOS0mxCafYhlNswxn0538P7tS_afBvoJuU2A |
CitedBy_id | crossref_primary_10_1016_j_chemosphere_2023_138251 crossref_primary_10_3390_ijms222312714 crossref_primary_10_1016_j_ecoenv_2024_116359 crossref_primary_10_47470_0869_7922_2023_31_1_47_53 crossref_primary_10_1016_j_chemosphere_2019_125416 crossref_primary_10_1177_07482337231177753 crossref_primary_10_1002_tox_22376 crossref_primary_10_1016_j_ntt_2019_03_001 crossref_primary_10_2478_aiht_2019_70_3263 crossref_primary_10_1016_j_aquatox_2018_03_022 crossref_primary_10_1016_j_scitotenv_2021_149938 crossref_primary_10_1002_etc_3951 crossref_primary_10_1007_s00401_019_02033_9 crossref_primary_10_1007_s10646_024_02763_x crossref_primary_10_2903_j_efsa_2021_6599 crossref_primary_10_1016_j_ecoenv_2019_01_057 crossref_primary_10_1039_C8RA07871H crossref_primary_10_1016_j_chemosphere_2018_12_011 crossref_primary_10_1016_j_aquatox_2022_106246 crossref_primary_10_1007_s00128_022_03645_w crossref_primary_10_1016_j_toxlet_2018_05_020 crossref_primary_10_1111_gbb_12460 crossref_primary_10_1016_j_scitotenv_2022_153623 crossref_primary_10_3390_ijms17122137 crossref_primary_10_3390_life14050640 crossref_primary_10_1007_s11356_020_07902_5 crossref_primary_10_1016_j_ecoenv_2021_112917 crossref_primary_10_1016_j_scitotenv_2019_134299 crossref_primary_10_1021_acs_est_9b00637 crossref_primary_10_1016_j_scitotenv_2019_134870 crossref_primary_10_3389_fnins_2018_00615 crossref_primary_10_3390_jmse8020073 crossref_primary_10_1016_j_scitotenv_2020_141878 crossref_primary_10_3389_fphar_2022_837810 crossref_primary_10_1016_j_ntt_2016_02_004 crossref_primary_10_1021_acs_est_3c10682 crossref_primary_10_1016_j_cbpc_2023_109584 crossref_primary_10_1007_s12403_021_00384_x crossref_primary_10_1007_s40572_018_0185_0 crossref_primary_10_1016_j_brainresbull_2019_10_002 crossref_primary_10_1016_j_scitotenv_2022_156027 crossref_primary_10_3390_toxics11040353 crossref_primary_10_1080_03601234_2023_2232277 crossref_primary_10_1007_s11596_019_1995_5 crossref_primary_10_1016_j_chemosphere_2019_02_174 crossref_primary_10_3390_molecules28176303 crossref_primary_10_1016_j_brainresbull_2022_01_004 |
Cites_doi | 10.1016/j.neuropharm.2004.07.034 10.1007/s00213-013-3212-8 10.1016/S0161-813X(02)00031-1 10.1096/fj.14-260901 10.1016/j.tox.2006.10.015 10.1093/toxsci/kfr111 10.1016/S0161-813X(01)00063-8 10.1016/j.neuro.2008.12.015 10.1289/ehp.5619 10.1289/ehp.02110507 10.1016/S0959-437X(00)00074-5 10.1016/j.bbr.2012.08.032 10.1016/S0166-4328(97)00175-7 10.1038/sj.jes.7500507 10.1006/pest.1999.2440 10.1016/j.envint.2012.07.007 10.1080/15459620902850907 10.1016/0168-9525(94)90091-4 10.1016/j.taap.2005.06.003 10.1016/0306-4522(92)90388-I 10.1111/j.1471-4159.1990.tb05803.x 10.1016/0305-0491(88)90156-3 10.1016/j.taap.2006.07.011 10.1016/0091-3057(93)90532-X 10.1289/ehp.7254 10.1016/j.biopsych.2005.02.002 10.1007/s00420-003-0470-5 10.1016/S0041-008X(03)00326-0 10.1016/S0892-0362(01)00170-2 10.1002/ps.2780270406 10.1074/jbc.M113.485227 10.1016/0041-008X(91)90270-O 10.1016/j.neuro.2008.09.011 10.1097/FPC.0b013e3280119d62 10.1016/j.neuro.2011.12.016 10.1186/1756-6606-4-26 10.1038/mp.2012.29 10.1007/BF01277656 10.1093/toxsci/kfp258 10.1073/pnas.79.14.4456 10.1016/j.envres.2008.03.002 10.1126/science.2953072 10.1016/j.ntt.2011.06.004 10.1289/ehp.0901275 10.1146/annurev.en.34.010189.000453 10.1038/379606a0 10.1016/S0300-483X(01)00569-8 10.1017/S0317167100041536 10.1016/j.ijheh.2011.12.003 10.1093/toxsci/kfm192 10.1007/BF01239644 10.1523/JNEUROSCI.18-06-01979.1998 10.1016/j.envres.2006.11.011 10.1002/aja.1002030302 10.1124/jpet.108.141713 10.1038/79951 10.1001/archneur.1978.00500310065014 10.1016/S0306-4522(98)00555-7 10.1016/j.ejphar.2006.06.042 |
ContentType | Journal Article |
Copyright | The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2015 |
Copyright_xml | – notice: The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. – notice: The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2015 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1093/toxsci/kfv087 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1096-0929 |
EndPage | 243 |
ExternalDocumentID | 10_1093_toxsci_kfv087 25912032 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: R01ES015991 – fundername: NIEHS NIH HHS grantid: R56ES018863 – fundername: NIEHS NIH HHS grantid: R21ES013828 – fundername: NIEHS NIH HHS grantid: P30ES005022 |
GroupedDBID | --- --K -E4 .2P .I3 .ZR 0R~ 123 18M 1B1 1TH 1~5 29Q 2WC 4.4 48X 4G. 53G 5RE 5VS 5WA 5WD 7-5 70D A8Z AABZA AACTN AACZT AAEDT AAHBH AAIMJ AAJKP AAJQQ AALRI AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AAQXK AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT AAXUO ABEUO ABIXL ABJNI ABKDP ABMAC ABMNT ABNHQ ABNKS ABPTD ABQLI ABQTQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACMRT ACUFI ACUTJ ACUTO ADBBV ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADMUD ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXEN AGINJ AGKEF AGQXC AGSYK AHXPO AIJHB AJEEA AKHUL AKRWK AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APWMN AQDSO ARIXL ASPBG ATGXG ATTQO AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM CAG CDBKE CGR COF CS3 CUY CVF CZ4 DAKXR DIK DILTD DM4 DU5 D~K E3Z EBD EBS ECM EDH EE~ EIF EJD ELUNK EMOBN ESTFP F5P F9B FDB FEDTE FGOYB FHSFR FIRID FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HH5 HVGLF HW0 HZ~ I-F IHE IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN LG5 M-Z M49 N9A NGC NLBLG NOMLY NOYVH NPM NQ- NTWIH NU- NVLIB O-L O0~ O9- OAWHX OBOKY OCZFY ODMLO OHT OJQWA OJZSN OK1 OPAEJ OWPYF O~Y P2P PAFKI PB- PEELM Q1. Q5Y R2- R44 RD5 RIG RNI ROL ROX RPZ RUSNO RW1 RXO RZO SSZ SV3 TJX TLC TR2 UHS W8F WOQ X7H XPP YAYTL YCJ YKOAZ YXANX ZGI ZKX ZMT ZXP ~02 ~91 AASNB AAYXX CITATION KC5 5PM |
ID | FETCH-LOGICAL-c387t-14afee80a0a9dc36cf4e5468b13f42d2b0d2644b5eba6a2e66e828272de0f3473 |
ISSN | 1096-6080 |
IngestDate | Tue Sep 17 21:17:14 EDT 2024 Thu Sep 26 15:50:17 EDT 2024 Tue Oct 15 23:52:11 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | developmental exposure locomotor activity zebrafish dopamine pyrethroid |
Language | English |
License | The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c387t-14afee80a0a9dc36cf4e5468b13f42d2b0d2644b5eba6a2e66e828272de0f3473 |
OpenAccessLink | https://academic.oup.com/toxsci/article-pdf/146/2/235/16688279/kfv087.pdf |
PMID | 25912032 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4517053 crossref_primary_10_1093_toxsci_kfv087 pubmed_primary_25912032 |
PublicationCentury | 2000 |
PublicationDate | 2015-08-01 |
PublicationDateYYYYMMDD | 2015-08-01 |
PublicationDate_xml | – month: 08 year: 2015 text: 2015-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Toxicological sciences |
PublicationTitleAlternate | Toxicol Sci |
PublicationYear | 2015 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 14551781 - Int Arch Occup Environ Health. 2004 Jan;77(1):67-72 21663703 - Mol Brain. 2011;4:26 12003754 - Environ Health Perspect. 2002 May;110(5):507-14 16859670 - Eur J Pharmacol. 2006 Aug 21;544(1-3):58-68 23912772 - Psychopharmacology (Berl). 2014 Jan;231(1):109-22 8628395 - Nature. 1996 Feb 15;379(6566):606-12 22508465 - Mol Psychiatry. 2012 Sep;17(9):946-54 6956874 - Proc Natl Acad Sci U S A. 1982 Jul;79(14):4456-60 3404444 - J Pharmacol Exp Ther. 1988 Aug;246(2):514-21 21741476 - Neurotoxicol Teratol. 2011 Nov-Dec;33(6):668-73 11792535 - Neurotoxicol Teratol. 2001 Nov-Dec;23(6):665-73 25630971 - FASEB J. 2015 May;29(5):1960-72 1977890 - J Neurochem. 1990 Dec;55(6):2111-6 17140720 - Toxicology. 2007 Jan 18;229(3):194-205 8332631 - Pharmacol Biochem Behav. 1993 Jul;45(3):729-32 2006507 - Toxicol Appl Pharmacol. 1991 Mar 15;108(1):78-85 20129874 - Environ Health Perspect. 2010 Jun;118(6):742-8 11017081 - Nat Genet. 2000 Oct;26(2):216-20 15687048 - Environ Health Perspect. 2005 Feb;113(2):123-36 11829414 - Neurotoxicology. 2001 Dec;22(6):811-7 14575646 - Toxicol Appl Pharmacol. 2003 Nov 1;192(3):287-93 2872638 - Neurotoxicology. 1986 Spring;7(1):143-53 8589427 - Dev Dyn. 1995 Jul;203(3):253-310 22954718 - Behav Brain Res. 2013 Jan 1;236(1):139-47 19459224 - Neurotoxicology. 2009 Mar;30(2):274-80 22892382 - Environ Int. 2012 Nov 1;48:109-20 12428726 - Neurotoxicology. 2002 Oct;23(4-5):537-44 22245043 - Neurotoxicology. 2012 Aug;33(4):810-6 16736054 - J Expo Sci Environ Epidemiol. 2007 Jul;17(4):331-49 17728286 - Toxicol Sci. 2007 Nov;100(1):168-79 19306213 - J Occup Environ Hyg. 2009 Jun;6(6):341-52 17496723 - Pharmacogenet Genomics. 2007 Apr;17(4):237-53 2953072 - Science. 1987 May 8;236(4802):719-22 15567422 - Neuropharmacology. 2004 Dec;47(8):1117-34 566540 - Arch Neurol. 1978 Jul;35(7):463-9 1349263 - Can J Neurol Sci. 1992 Feb;19(1 Suppl):147-52 18952124 - Neurotoxicology. 2009 Jan;30(1):52-8 18436207 - Environ Res. 2008 Jul;107(3):343-50 1978240 - Mol Pharmacol. 1990 Oct;38(4):531-41 22218106 - Int J Hyg Environ Health. 2012 Sep;215(5):487-95 21555338 - Toxicol Sci. 2011 Aug;122(2):512-25 17258193 - Environ Res. 2007 Jun;104(2):266-74 2905952 - Comp Biochem Physiol C. 1988;91(2):371-5 9708845 - Behav Brain Res. 1998 Jul;94(1):127-52 8036717 - Trends Genet. 1994 May;10(5):152-9 16956637 - Toxicol Appl Pharmacol. 2006 Nov 15;217(1):25-34 10826982 - Curr Opin Genet Dev. 2000 Jun;10(3):252-6 2539040 - Annu Rev Entomol. 1989;34:77-96 9295170 - J Neural Transm (Vienna). 1997;104(4-5):341-62 1357592 - Neuroscience. 1992 Sep;50(1):137-47 1498477 - Bull Environ Contam Toxicol. 1992 Sep;49(3):402-9 12515682 - Environ Health Perspect. 2003 Jan;111(1):79-84 15949994 - Biol Psychiatry. 2005 Jun 1;57(11):1239-47 10366011 - Neuroscience. 1999;91(2):537-47 16673815 - Biomed Environ Sci. 2006 Feb;19(1):27-34 18698001 - J Pharmacol Exp Ther. 2008 Nov;327(2):554-60 9482784 - J Neurosci. 1998 Mar 15;18(6):1979-86 23754283 - J Biol Chem. 2013 Aug 2;288(31):22451-9 16005927 - Toxicol Appl Pharmacol. 2006 Mar 15;211(3):188-97 19861644 - Toxicol Sci. 2010 Jan;113(1):177-86 11812616 - Toxicology. 2002 Feb 1;171(1):3-59 2016080102451721000_146.2.235.39 2016080102451721000_146.2.235.38 2016080102451721000_146.2.235.37 2016080102451721000_146.2.235.36 2016080102451721000_146.2.235.35 2016080102451721000_146.2.235.33 2016080102451721000_146.2.235.32 2016080102451721000_146.2.235.30 Barton (2016080102451721000_146.2.235.4) 1990; 38 Fortin (2016080102451721000_146.2.235.19) 2008; 107 2016080102451721000_146.2.235.49 2016080102451721000_146.2.235.48 2016080102451721000_146.2.235.6 2016080102451721000_146.2.235.47 2016080102451721000_146.2.235.7 2016080102451721000_146.2.235.46 2016080102451721000_146.2.235.45 2016080102451721000_146.2.235.44 2016080102451721000_146.2.235.43 Hudson (2016080102451721000_146.2.235.31) 1986; 7 2016080102451721000_146.2.235.42 2016080102451721000_146.2.235.8 2016080102451721000_146.2.235.9 2016080102451721000_146.2.235.40 2016080102451721000_146.2.235.50 2016080102451721000_146.2.235.2 2016080102451721000_146.2.235.3 2016080102451721000_146.2.235.1 Berkowitz (2016080102451721000_146.2.235.5) 2003; 111 2016080102451721000_146.2.235.18 2016080102451721000_146.2.235.17 2016080102451721000_146.2.235.15 2016080102451721000_146.2.235.59 2016080102451721000_146.2.235.14 2016080102451721000_146.2.235.58 2016080102451721000_146.2.235.13 Liu (2016080102451721000_146.2.235.41) 2006; 19 2016080102451721000_146.2.235.57 2016080102451721000_146.2.235.12 2016080102451721000_146.2.235.11 2016080102451721000_146.2.235.55 2016080102451721000_146.2.235.10 2016080102451721000_146.2.235.54 2016080102451721000_146.2.235.52 2016080102451721000_146.2.235.51 2016080102451721000_146.2.235.61 2016080102451721000_146.2.235.60 Shafer (2016080102451721000_146.2.235.56) 2005; 113 Eells (2016080102451721000_146.2.235.16) 1988; 246 2016080102451721000_146.2.235.29 2016080102451721000_146.2.235.28 2016080102451721000_146.2.235.27 2016080102451721000_146.2.235.26 Robertson (2016080102451721000_146.2.235.53) 1992; 19 2016080102451721000_146.2.235.25 2016080102451721000_146.2.235.24 Jones (2016080102451721000_146.2.235.34) 1998; 18 2016080102451721000_146.2.235.23 2016080102451721000_146.2.235.22 2016080102451721000_146.2.235.21 2016080102451721000_146.2.235.65 2016080102451721000_146.2.235.20 2016080102451721000_146.2.235.64 2016080102451721000_146.2.235.63 2016080102451721000_146.2.235.62 |
References_xml | – ident: 2016080102451721000_146.2.235.27 doi: 10.1016/j.neuropharm.2004.07.034 – ident: 2016080102451721000_146.2.235.10 doi: 10.1007/s00213-013-3212-8 – ident: 2016080102451721000_146.2.235.6 doi: 10.1016/S0161-813X(02)00031-1 – ident: 2016080102451721000_146.2.235.52 doi: 10.1096/fj.14-260901 – ident: 2016080102451721000_146.2.235.48 – ident: 2016080102451721000_146.2.235.47 doi: 10.1016/j.tox.2006.10.015 – ident: 2016080102451721000_146.2.235.28 doi: 10.1093/toxsci/kfr111 – ident: 2016080102451721000_146.2.235.35 doi: 10.1016/S0161-813X(01)00063-8 – ident: 2016080102451721000_146.2.235.55 doi: 10.1016/j.neuro.2008.12.015 – volume: 111 start-page: 79 year: 2003 ident: 2016080102451721000_146.2.235.5 article-title: Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort publication-title: Environ. Health Perspect. doi: 10.1289/ehp.5619 contributor: fullname: Berkowitz – volume: 246 start-page: 514 year: 1988 ident: 2016080102451721000_146.2.235.16 article-title: Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Eells – ident: 2016080102451721000_146.2.235.65 doi: 10.1289/ehp.02110507 – ident: 2016080102451721000_146.2.235.14 doi: 10.1016/S0959-437X(00)00074-5 – ident: 2016080102451721000_146.2.235.58 doi: 10.1016/j.bbr.2012.08.032 – ident: 2016080102451721000_146.2.235.62 doi: 10.1016/S0166-4328(97)00175-7 – ident: 2016080102451721000_146.2.235.7 doi: 10.1038/sj.jes.7500507 – ident: 2016080102451721000_146.2.235.37 doi: 10.1006/pest.1999.2440 – ident: 2016080102451721000_146.2.235.1 doi: 10.1016/j.envint.2012.07.007 – ident: 2016080102451721000_146.2.235.9 doi: 10.1080/15459620902850907 – ident: 2016080102451721000_146.2.235.15 doi: 10.1016/0168-9525(94)90091-4 – ident: 2016080102451721000_146.2.235.17 doi: 10.1016/j.taap.2005.06.003 – ident: 2016080102451721000_146.2.235.30 doi: 10.1016/0306-4522(92)90388-I – ident: 2016080102451721000_146.2.235.2 doi: 10.1111/j.1471-4159.1990.tb05803.x – volume: 19 start-page: 27 year: 2006 ident: 2016080102451721000_146.2.235.41 article-title: Tyrosine hydroxylase as a target for deltamethrin in the nigrostriatal dopaminergic pathway publication-title: Biomed. Environ. Sci. contributor: fullname: Liu – ident: 2016080102451721000_146.2.235.13 doi: 10.1016/0305-0491(88)90156-3 – ident: 2016080102451721000_146.2.235.29 doi: 10.1016/j.taap.2006.07.011 – ident: 2016080102451721000_146.2.235.43 doi: 10.1016/0091-3057(93)90532-X – volume: 113 start-page: 123 year: 2005 ident: 2016080102451721000_146.2.235.56 article-title: Developmental neurotoxicity of pyrethroid insecticides: Critical review and future research needs publication-title: Environ. Health Perspect. doi: 10.1289/ehp.7254 contributor: fullname: Shafer – ident: 2016080102451721000_146.2.235.54 doi: 10.1016/j.biopsych.2005.02.002 – ident: 2016080102451721000_146.2.235.25 doi: 10.1007/s00420-003-0470-5 – ident: 2016080102451721000_146.2.235.21 doi: 10.1016/S0041-008X(03)00326-0 – ident: 2016080102451721000_146.2.235.39 doi: 10.1016/S0892-0362(01)00170-2 – ident: 2016080102451721000_146.2.235.12 doi: 10.1002/ps.2780270406 – ident: 2016080102451721000_146.2.235.50 doi: 10.1074/jbc.M113.485227 – ident: 2016080102451721000_146.2.235.18 doi: 10.1016/0041-008X(91)90270-O – ident: 2016080102451721000_146.2.235.42 doi: 10.1016/j.neuro.2008.09.011 – ident: 2016080102451721000_146.2.235.51 doi: 10.1097/FPC.0b013e3280119d62 – ident: 2016080102451721000_146.2.235.20 doi: 10.1016/j.neuro.2011.12.016 – ident: 2016080102451721000_146.2.235.24 doi: 10.1186/1756-6606-4-26 – ident: 2016080102451721000_146.2.235.38 doi: 10.1038/mp.2012.29 – volume: 38 start-page: 531 year: 1990 ident: 2016080102451721000_146.2.235.4 article-title: Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells publication-title: Mol. Pharmacol. contributor: fullname: Barton – ident: 2016080102451721000_146.2.235.8 doi: 10.1007/BF01277656 – ident: 2016080102451721000_146.2.235.11 doi: 10.1093/toxsci/kfp258 – ident: 2016080102451721000_146.2.235.44 doi: 10.1073/pnas.79.14.4456 – volume: 107 start-page: 343 year: 2008 ident: 2016080102451721000_146.2.235.19 article-title: Biological monitoring of exposure to pyrethrins and pyrethroids in a metropolitan population of the Province of Quebec, Canada publication-title: Environ. Res. doi: 10.1016/j.envres.2008.03.002 contributor: fullname: Fortin – ident: 2016080102451721000_146.2.235.64 doi: 10.1126/science.2953072 – ident: 2016080102451721000_146.2.235.40 doi: 10.1016/j.ntt.2011.06.004 – ident: 2016080102451721000_146.2.235.3 doi: 10.1289/ehp.0901275 – ident: 2016080102451721000_146.2.235.60 doi: 10.1146/annurev.en.34.010189.000453 – ident: 2016080102451721000_146.2.235.22 doi: 10.1038/379606a0 – ident: 2016080102451721000_146.2.235.61 doi: 10.1016/S0300-483X(01)00569-8 – volume: 19 start-page: 147 year: 1992 ident: 2016080102451721000_146.2.235.53 article-title: Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson’s disease: sites of action and implications for the pathogenesis of dyskinesias publication-title: Can. J. Neurol. Sci.(Le journal canadien des sciences neurologiques) doi: 10.1017/S0317167100041536 contributor: fullname: Robertson – ident: 2016080102451721000_146.2.235.23 – ident: 2016080102451721000_146.2.235.49 doi: 10.1016/j.ijheh.2011.12.003 – ident: 2016080102451721000_146.2.235.26 doi: 10.1093/toxsci/kfm192 – ident: 2016080102451721000_146.2.235.32 doi: 10.1007/BF01239644 – volume: 18 start-page: 1979 year: 1998 ident: 2016080102451721000_146.2.235.34 article-title: Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.18-06-01979.1998 contributor: fullname: Jones – volume: 7 start-page: 143 year: 1986 ident: 2016080102451721000_146.2.235.31 article-title: Neurobehavioral effects of permethrin are associated with alterations in regional levels of biogenic amine metabolites and amino acid neurotransmitters publication-title: Neurotoxicology contributor: fullname: Hudson – ident: 2016080102451721000_146.2.235.45 doi: 10.1016/j.envres.2006.11.011 – ident: 2016080102451721000_146.2.235.36 doi: 10.1002/aja.1002030302 – ident: 2016080102451721000_146.2.235.63 doi: 10.1124/jpet.108.141713 – ident: 2016080102451721000_146.2.235.46 doi: 10.1038/79951 – ident: 2016080102451721000_146.2.235.57 doi: 10.1001/archneur.1978.00500310065014 – ident: 2016080102451721000_146.2.235.59 doi: 10.1016/S0306-4522(98)00555-7 – ident: 2016080102451721000_146.2.235.33 doi: 10.1016/j.ejphar.2006.06.042 |
SSID | ssj0011609 |
Score | 2.4290338 |
Snippet | Pyrethroids are commonly used insecticides that are considered to pose little risk to human health. However, there is an increasing concern that children are... |
SourceID | pubmedcentral crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 235 |
SubjectTerms | Alteration in Zebrafish Dopamine Function by Deltamethrin Animals Female Gene Expression Regulation, Developmental - drug effects In Vitro Techniques Insecticides - toxicity Methylphenidate - pharmacology Nitriles - toxicity Pregnancy Prenatal Exposure Delayed Effects Pyrethrins - toxicity Receptors, Dopamine D1 - genetics Receptors, Dopamine D2 - genetics Swimming Zebrafish - embryology |
Title | Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25912032 https://pubmed.ncbi.nlm.nih.gov/PMC4517053 |
Volume | 146 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiEkhKDAKDf5AfVlTec4zu2xKqBpFzSNTky8VIljaxGQTG2KNn4Gv4sfxXHsOAnsYfASRbmcqj1fj4_t73wHoTcJoVlMGHNkFDGHeUw6MCxIh4O3iRBBmNQCpscfgv0zdnDunw8GvzqspU2VTvmPG-tK_sercA38qqpk_8Gz1ihcgHPwLxzBw3C8lY87jB8VvcTXKlEdoVd5oSSMS7X4tztPNmuxrpnuyqNFZQoKah7sW5gyf6vL_3JeK1Cr9zQzVtdhKekO3vSEa5ieRyVXHL5SsetN8wmw9VltQct8fdHNdxflVc5tfDXDbWf_SEeaRS6l4h18nNr9n1452EGi-iSe2rvzsrw0ZBCh1pHbO7bf31G5yndn0-6ihutbSl0Th2Fm5QREN3maivYaic0CSRO8zQJm3plEm1CsZVDMqE61GNRfA4YW06rKK_gF4OSL_E5MAtCT5v5jyLRERr2F7y21gaV-_Q7aphD2IN5uzw5PPx3aXS03qClH9ssZzVcwsKcN7GkDvRzJJkZ90m4nC1o8RA_M9AXPNBYfoYEohujusSFoDNH4REuhX0_woq3sW0_wGJ-0IunXQ3RfrxdjXQb3GP3sYRl3sYwbLGONZdxiGRssY3iqi2WssIxbLE9wH8kTDDjGFse4wbGyY3H8BJ29f7eY7zumX4jDvSisHJclUoiIJCSJM-4FXDLhsyBKXU8ymtGUZCr9T32RJkFCRRCIiEY0pJkg0mOh9xRtFWUhniHM_NiDCMa5mzIWMTfOfBb7saQhSQlLxQiNGw8tL7UszPJGLIzQjnabfYz6sUuJR0co7DnUPqAE3_t3ivyiFn5nvhK_8p7f9sNfoHvtn-sl2qpWG_EKcugqfW2g-RsHrNTz |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Developmental+Deltamethrin+Exposure+Causes+Persistent+Changes+in+Dopaminergic+Gene+Expression%2C+Neurochemistry%2C+and+Locomotor+Activity+in+Zebrafish&rft.jtitle=Toxicological+sciences&rft.au=Kung%2C+Tiffany+S.&rft.au=Richardson%2C+Jason+R.&rft.au=Cooper%2C+Keith+R.&rft.au=White%2C+Lori+A.&rft.date=2015-08-01&rft.issn=1096-6080&rft.eissn=1096-0929&rft.volume=146&rft.issue=2&rft.spage=235&rft.epage=243&rft_id=info:doi/10.1093%2Ftoxsci%2Fkfv087&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_toxsci_kfv087 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6080&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6080&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6080&client=summon |